We're building Siequi toward pilot partnerships with dermatologists, ahead of a seed conversation. This page is a brief overview — deeper materials are shared directly with interested investors and partners.
Siequi is a symptom companion for chronic dermatological conditions — psoriasis and eczema initially — paired with a lightweight, consent-based doctor portal. The product is built on deterministic, explainable analytics rather than machine learning, and on validated clinical questionnaires already in dermatological use.
We're speaking with investors and strategic partners interested in the intersection of chronic disease management, patient-reported outcomes, and India's ABDM/FHIR interoperability landscape. If that overlaps with your thesis, we'd welcome a conversation.